Overview

Safety and Pharmacokinetics of Azelaic Acid Foam, 15% in Papulopustular Rosacea

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
Assessment of pharmacokinetics of Azelaic Acid Foam after repeated skin application and in comparison to Azelaic Acid gel. Assessment of safety after repeated skin application.
Phase:
Phase 1
Details
Lead Sponsor:
Bayer
LEO Pharma
Collaborator:
Bayer
Treatments:
Azelaic acid